View all adult cancer types
View all pediatric cancer types
Susan F. Smith Center for Women's Cancers
Gynecologic CancerBlood CancersCancer Genetics and PreventionCutaneous (Skin) CancerGastrointestinal CancerGenitourinary CancerHead and Neck CancerHematologyMelanomaNeuro-OncologySarcomaStem Cell TransplantThoracic (Lung) Cancer
Blood DisordersBrain TumorsHematologic MalignanciesSolid TumorsStem Cell Transplant
Dana-Farber Cancer Institute has launched DiscoverCareBelieve.org, a new platform to illustrate what sets Dana-Farber apart — in research discovery... in expert, compassionate care... and in our strong belief in progress for people with cancer everywhere.WebsiteVideoWhat do you #DiscoverCareBelieve?
In a new study, researchers at Dana-Farber Cancer Institute show that disruptions to the activity of cell proteins can reveal which genetic mutations lead to disease and which are mere bystanders.
Clinicians at Dana-Farber/Brigham and Women'’s Cancer Center are now armed with specialized tests to create a precise "tumor profile" for each patient's cancer. Learn about the latest thinking in precision cancer medicine from our researchers and clinicians, and explore a searchable database of clinical trials that focus on targeted therapies by disease, gene, and mutation.
Bruce Spiegelman, PhD, Dana-Farber Cancer Institute, has received Belgium's most important international scientific prize for his contributions to understanding the mechanisms of metabolic disorders.
Dana-Farber Cancer Institute and Harvard T.H. Chan School of Public Health in Boston and the Irish Cancer Society have formed the Boston-Ireland Prostate Cancer Collaboration. This new entity will conduct and facilitate exchanges of researchers and knowledge between Boston and Ireland.
Dana-Farber researchers report that combination treatment with olaparib and BKM120 was safe and yielded evidence of clinical benefit for women with triple-negative breast cancer and for those with high-grade serous ovarian cancer in a phase I clinical trial.
Dana-Farber nutritionist Stacy Kennedy, MPH, discussed the importance of maintaining good nutrition for cancer patients.
Dr. Judy Garber discussed breast cancer among men and the lack of awareness despite a surge in news surrounding the BRCA gene.
Dr. Mehra Golshan led a study that shows many patients are
opting for a mastectomy despite the high success rates a lumpectomy can offer.
Dr. F. Stephen Hodi co-led a study that found combining two drugs that unleash the immune system to attack cancer was significantly more effective in stifling tumors in melanoma patients than using just one of the treatments alone.
K. "Vish" Viswanath, PhD was a panelist for a discussion titled "Can E-cigarette Regulation Protect the Public’s Health? Making Sense of the Science."
Dr. Joanne Wolfe commented on the pressing need for improvements in the care of pediatric cancer patients, despite research showing increased survival rates in the group.
Dr. Rosalind Segal led a study that identified a protein critical to both the normal development of the brain and the development of medulloblastoma, a fast-growing brain tumor that usually strikes children younger than 10.
Dana-Farber's Mammography Van(20)
Bowdoin Street Health Center
Dana-Farber’s Mammography Van brings state-of-the-art breast cancer screening to the women of Greater Boston. To learn more or schedule an appointment, please call 617-632-1974. Visit is on the Web at www.dana-farber.org/mammographyvan. Dana-Farber’s Mammography Van is managed by Dana-Farber Cancer Institute’s Mobile Health program and possesses a valid license and certificate of inspection issued by the Massachusetts Department of Public Health.
Tai Chi for Optimal Health
3:00 PM - 4:30 PM
Smith Room, 330, Stoneman Patient Services Suite
An internal Chinese martial art practiced for both defense training and health benefits. Learn sitting and standing techniques as well as slow moving meditation. Open to patients and family members. Please register at 617-632-3322.
4:30 PM - 6:00 PM
Smith Room 330, Stoneman Patient Services Suite
Fine tune your mind/body skills and create balance among them. Open to patients and family members. Please register at 617-632-3322.
Patient referral information, clinical resources and more.
For adults:877-442-3324Quick access: Appointments as soon as the next day for new adult patientsFor children:888-733-4662
Search current cancer clinical trials at Dana-Farber.
There are many ways to support Dana-Farber and the Jimmy Fund.
Top-ranked cancer center in New England for adults — #1 in the nation for children's cancer
Insight features the latest in cancer care and research news from Dana-Farber.Read the blog
Stay current on the latest news by signing up for Spotlight, our email newsletter.View current issueSubscribe now
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: